Attralus Therapeutics
0 followers
‌
Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.
Industries
Headquarters
Employees
Links
Org chart
Mark Timney
CEO
Mark Timney
Collapse
Spencer Guthrie
Co-Founder & COO
Glen Firestone
Chief Business Officer
Gregory Bell
Chief Medical Officer
Jonathan Wall
Co-Founder & Interim Chief Scientific Officer
James Testa
VP, Finance
Michael L. Klein
Head, CMC
Christine Huh
Head, Human Resources
Andy Vick
Vice President, Head Of Toxicology, Drug Disposition, And Pk/pd
Daniel Kim
Associate Director, Translational Medicine Operations
Lesley Davis
Director Of Quality
Mike Klein
Senior Vice President, Head of CMC
Nicolas Angell
Executive Director, Analytical and Formulation Development
Dave Conroy
Head of Program Management
Matthew Meldorf
Senior Vice President Clinical Development
